These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 36853018)

  • 1. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
    Wu H; Guo C; Wang C; Xu J; Zheng S; Duan J; Li Y; Bai H; Xu Q; Ning F; Wang F; Yang Q
    Cancer Sci; 2023 Jun; 114(6):2609-2621. PubMed ID: 36853018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.
    Khalafallah AM; Huq S; Jimenez AE; Serra R; Bettegowda C; Mukherjee D
    Neurosurgery; 2021 Feb; 88(3):477-486. PubMed ID: 32674143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
    Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
    Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastoma.
    Yang K; Shi Y; Luo M; Mao M; Zhang X; Chen C; Liu Y; He Z; Liu Q; Wang W; Luo C; Yin W; Wang C; Niu Q; Zeng H; Bian XW; Ping YF
    Oncoimmunology; 2022; 11(1):2030020. PubMed ID: 35096487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.
    Qazi MA; Vora P; Venugopal C; Sidhu SS; Moffat J; Swanton C; Singh SK
    Ann Oncol; 2017 Jul; 28(7):1448-1456. PubMed ID: 28407030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspective.
    Wang L; Li X; Xu C; Wang D; Ma C; Wang Z; Li Y; Li Z
    J Transl Med; 2024 Jun; 22(1):551. PubMed ID: 38851695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
    Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
    J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
    Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
    Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.
    Petterson SA; Sørensen MD; Kristensen BW
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):975-985. PubMed ID: 32791527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell RNA sequencing reveals intra-tumoral heterogeneity of glioblastoma and a pro-tumor subset of tumor-associated macrophages characterized by EZH2 overexpression.
    Chen X; Chen Y; Chen X; Wei P; Lin Y; Wu Z; Lin Z; Kang D; Ding C
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166534. PubMed ID: 36057370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
    Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Immunol; 2020; 11():835. PubMed ID: 32457755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
    DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
    Front Immunol; 2020; 11():1402. PubMed ID: 32765498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma heterogeneity at single cell resolution.
    Eisenbarth D; Wang YA
    Oncogene; 2023 Jun; 42(27):2155-2165. PubMed ID: 37277603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression.
    Yeo AT; Rawal S; Delcuze B; Christofides A; Atayde A; Strauss L; Balaj L; Rogers VA; Uhlmann EJ; Varma H; Carter BS; Boussiotis VA; Charest A
    Nat Immunol; 2022 Jun; 23(6):971-984. PubMed ID: 35624211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.
    Mercatelli N; Galardi S; Ciafrè SA
    Int Rev Cell Mol Biol; 2017; 333():269-323. PubMed ID: 28729027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma Multiforme.
    Ramezani S; Vousooghi N; Joghataei MT; Chabok SY
    Cancer Biother Radiopharm; 2019 Aug; 34(6):345-354. PubMed ID: 31411929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.
    Knudsen AM; Halle B; Cédile O; Burton M; Baun C; Thisgaard H; Anand A; Hubert C; Thomassen M; Michaelsen SR; Olsen BB; Dahlrot RH; Bjerkvig R; Lathia JD; Kristensen BW
    Neuro Oncol; 2022 Jul; 24(7):1074-1087. PubMed ID: 34964899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.